NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

CompletedN/A

Sponsor: Pfizer

Conditions: Acromegaly

Interventions: Somavert (Pegvisomant)

The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy of this drug.

Eligibility overview

Sex: ALL

Age: 0 Days to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Patients need to be administered Somavert (Pegvisomant) in order to be enrolled in the surveillance.

Exclusion Criteria:

Patients not administered Somavert (Pegvisomant).